Oxoject Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.


Because of the specific action of oxytocin upon the uterine musculature, it is recommended as an aid in the management of the following conditions:

1)  To precipitate labor

2)  To accelerate normal parturition

3)  Postpartum evacuation of uterine debris

4)  Postoperative contraction of the uterus following a cesarean section and control of uterine hemorrhage.

Oxytocin will contract the smooth muscle cells of the mammary gland to induce milk let-down if the udder is in a proper physiological state.


There is currently no drug history available for this drug.

Other Information

OXOJect (Oxytocin injection) is a sterile aqueous solution of highly purified oxytocic principle derived by synthesis or obtained from the posterior lobe of the putuitary gland of healthy domestic animals used for food by humans.  OXOJect (Oxytocin injection) contains 20 USP Units of oxytocin and less than 0.4 units of presser activity per mL.  Each mL of sterile solution also contains 0.9% w/v sodium chloride, 0.5% w/v chlorobutanol (as a preservative), with water for injection q.s. and pH adjusted to 3.0 to 5.0 with acetic acid.

Oxoject Manufacturers

  • Henry Schein Butler Animal Health
    Oxoject (Oxytocin Injection) Injection, Solution [Henry Schein Butler Animal Health]

Login To Your Free Account